Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Albinism with pulmonary fibrosis: Hermansky-Pudlak syndrome.
Winiarska A, Błasińska K, Radzikowska E. Winiarska A, et al. Pol Arch Intern Med. 2020 Sep 30;130(9):807-808. doi: 10.20452/pamw.15418. Epub 2020 Jun 4. Pol Arch Intern Med. 2020. PMID: 32495608 Free article. No abstract available.
A woman with multiple pulmonary nodules.
Winiarska A, Maksymiuk B, Radzikowska E. Winiarska A, et al. Pol Arch Intern Med. 2019 Oct 30;129(10):719-720. doi: 10.20452/pamw.14903. Epub 2019 Jul 17. Pol Arch Intern Med. 2019. PMID: 31316045 Free article. No abstract available.
Pulmonary actinomycosis complicated by fistula of the chest wall.
Łyżwa E, Siemion-Szcześniak I, Sobiecka M, Kacprzak A, Winiarska A, Szołkowska M, Karuś K, Tomkowski W. Łyżwa E, et al. Among authors: winiarska a. Adv Respir Med. 2021;89(5):532-537. doi: 10.5603/ARM.a2021.0071. Epub 2021 Jul 16. Adv Respir Med. 2021. PMID: 34269403 Free article.
Kidneys in heart failure: Impact of flozins.
Stompór T, Winiarska A. Stompór T, et al. Among authors: winiarska a. Kardiol Pol. 2023;81(11):1071-1080. doi: 10.33963/v.kp.97844. Epub 2023 Nov 8. Kardiol Pol. 2023. PMID: 37937356 Free article. Review.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
40 results